Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
0
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and...